By HospiMedica International staff writers
Posted on 15 May 2020

Applied DNA Sciences Inc. (Stony Brook, NY, USA) has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) for the clinical use of the company’s patent-pending Linea COVID-19 RT-PCR test.

COVID-19 Diagnostic Kit: Applied DNA Applies to U.S. FDA for Emergency Use Authorization

The Linea COVID-19 assay kit is an rRT-PCR (reverse transcription, Real Time Polymerase Chain Reaction)-based assay designed to detect specific highly conserved target sequences of the SARS-CoV-2 Spike (S) gene.

Read more at HospiMedica